LATAM Creatine Supplements Market Size & Outlook, 2025-2033

LATAM Creatine Supplements Market Insights

Deep Market Insights analysis indicates that the LATAM Creatine Supplements Market size, which was USD 82.65 Million in 2024, is projected to attain USD 575.09 Million by 2033.
The market is expected to register a CAGR of 24.16% over the period 2026–2033.
In 2024, Creatine monohydrate emerged as the dominant Product/Form based on market size.
Buffered & blends is projected to register the fastest growth, positioning it as the most attractive Product/Form segment over the forecast horizon.

LATAM held 7.9% share of the global Creatine Supplements Market size in 2024.
United States is expected to remain the largest contributor to the global market size by 2033.
By 2033, Brazil is anticipated to record the highest growth in LATAM, with the market size expected to reach USD 229.25 Million.

Report Scope	Details
Base Year for Study	2024
Study Period	2021-2033
Historical Period	2021-2023
Forecast Period	2025-2033
Market Size In 2024	USD 82.65 Million
Market Size In 2033	USD 575.09 Million
Largest segment	Creatine monohydrate
Units	Revenue in USD Million
CAGR	24.16% (2025-2033)
Segmnetation Covered
LATAM	Brazil Mexico Argentina Colombia Chile
Product/Form	Creatine monohydrate Creatine HCl Buffered & blends Capsules & powders
End User	Athletes & sports Fitness enthusiasts Medical/older adults
Distribution	E-commerce Pharmacies & retail Specialty sports stores
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

LATAM	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
Brazil	XX.x	XX.x	XX.x	31.42	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Mexico	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Argentina	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Colombia	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Chile	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: DMI Analysis Company Publications, Primary Interviews.

Product/Form	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
Creatine monohydrate	XX.x	XX.x	XX.x	33.33	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Creatine HCl	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Buffered & blends	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Capsules & powders	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: DMI Analysis Company Publications, Primary Interviews.

End User	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
Athletes & sports	XX.x	XX.x	XX.x	45.11	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Fitness enthusiasts	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Medical/older adults	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: DMI Analysis Company Publications, Primary Interviews.

Distribution	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
E-commerce	XX.x	XX.x	XX.x	37.31	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Pharmacies & retail	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Specialty sports stores	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x